Literature DB >> 25926688

Proprotein convertase FURIN regulates T cell receptor-induced transactivation.

Zsuzsanna Ortutay1, Anna Oksanen1, Saara Aittomäki1, Csaba Ortutay1, Marko Pesu2.   

Abstract

Antigen emergence rapidly stimulates T cells, which leads to changes in cytokine production, cell proliferation, and differentiation. Some of the key molecules involved in these events, such as TGF-β1 and NOTCH1, are synthesized initially as inactive precursors and are proteolytically activated during T cell activation. PCSKs regulate proprotein maturation by catalyzing the proteolytic cleavage of their substrates. The prototype PCSK FURIN is induced upon TCR activation, and its expression in T cells is critical for the maintenance of peripheral immune tolerance. In this study, we tested the hypothesis that FURIN regulates T cell activation. Our data demonstrate that IL-2 is increased initially in FURIN-deficient mouse CD4(+) T cells, but the TCR-induced IL-2 mRNA expression is not sustained in the absence of FURIN. Accordingly, the inhibition of FURIN in human Jurkat T cell lines also results in a decrease in IL-2 production, whereas the overexpression of WT FURIN is associated with elevated IL-2 levels. In Jurkat cells, FURIN is dispensable for immediate TCR signaling steps, such as ERK, ZAP70, or LAT phosphorylation. However, with the use of gene reporter assays, we demonstrate that FURIN regulates the AP-1, NFAT, and NF-κB transcription factors. Finally, by performing a transcription factor-binding site enrichment analysis on FURIN-dependent transcriptomes, we identify the FURIN-regulated transcription factors in mouse CD4(+) T cell subsets. Collectively, our work confirms the hypothesis that the TCR-regulated protease FURIN plays an important role in T cell activation and that it can specifically modulate TCR-activated transactivation. © Society for Leukocyte Biology.

Entities:  

Keywords:  IL-2; T cell activation; phosphorylation; transcription factor

Mesh:

Substances:

Year:  2015        PMID: 25926688     DOI: 10.1189/jlb.2A0514-257RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development.

Authors:  Maria Vähätupa; Saara Aittomäki; Zuzet Martinez Cordova; Ulrike May; Stuart Prince; Hannele Uusitalo-Järvinen; Tero A Järvinen; Marko Pesu
Journal:  Oncoimmunology       Date:  2016-10-14       Impact factor: 8.110

2.  Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?

Authors:  Thomas Graier; Nicole Golob-Schwarzl; Wolfgang Weger; Theresa Benezeder; Clemens Painsi; Wolfgang Salmhofer; Peter Wolf
Journal:  Front Med (Lausanne)       Date:  2021-02-10

3.  Identification of Novel Genetic Regulatory Region for Proprotein Convertase FURIN and Interferon Gamma in T Cells.

Authors:  Zsuzsanna Ortutay; Anna Grönholm; Melina Laitinen; Melinda Keresztes-Andrei; Ismail Hermelo; Marko Pesu
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

4.  Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker.

Authors:  Bolun Zhou; Shugeng Gao
Journal:  Front Mol Biosci       Date:  2021-04-22

Review 5.  Mouse Models of Human Proprotein Convertase Insufficiency.

Authors:  Manita Shakya; Iris Lindberg
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

6.  Myeloid cell expressed proprotein convertase FURIN attenuates inflammation.

Authors:  Zuzet Martinez Cordova; Anna Grönholm; Ville Kytölä; Valentina Taverniti; Sanna Hämäläinen; Saara Aittomäki; Wilhelmiina Niininen; Ilkka Junttila; Antti Ylipää; Matti Nykter; Marko Pesu
Journal:  Oncotarget       Date:  2016-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.